-
Something wrong with this record ?
Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in BALB/c mice
M. Pohanka, O. Pavlis, H. Svobodova, J. Pikula
Language English Country Slovakia
Document type Research Support, Non-U.S. Gov't, Journal Article
NLK
Free Medical Journals
from 2008
PubMed Central
from 2008 to 2019
Europe PubMed Central
from 2008 to 2018
ProQuest Central
from 2008-06-01 to 2020-01-31
Open Access Digital Library
from 2008-01-01
Open Access Digital Library
from 2008-01-01
Open Access Digital Library
from 2009-06-19
Nursing & Allied Health Database (ProQuest)
from 2008-06-01 to 2020-01-31
Health & Medicine (ProQuest)
from 2008-06-01 to 2020-01-31
Public Health Database (ProQuest)
from 2008-06-01 to 2021-01-31
Sciendo
from 2009-06-19
ROAD: Directory of Open Access Scholarly Resources
from 2008
- MeSH
- Acetylcholine * immunology toxicity MeSH
- Cytokines drug effects MeSH
- Francisella tularensis pathogenicity MeSH
- Immunomodulation MeSH
- Mice, Inbred BALB C MeSH
- Neostigmine * immunology toxicity MeSH
- Parasympathetic Nervous System drug effects MeSH
- Tularemia * immunology complications mortality MeSH
- Research MeSH
- Inflammation immunology microbiology MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The present experiment was aimed at assessing the application of neostigmine, an acetylcholinesterase (AChE) pseudo-irreversible inhibitor with poor penetration through the hematoencephalitic barrier, and the neurotransmitter acetylcholine (ACh). The experiment was done to evaluate their ability to modulate an infectious disease: tularemia. Mice infected with Franciselle tularensis and exposed to either ACh or neostigmine had a higher mortality and spleen bacterial burden when compared to infected mice exposed to saline solution only. The activated cholinergic anti-inflammatory pathway suppressed pathways necessary for tularemia resolution. Administration of AChE inhibitors to the individuals suffering from tularemia is contra-indicatory. Drugs based on AChE inhibition should be restricted when tularemia or disease with a similar pathogenesis is suspected.
Centre of Biological Defense Techonin Czech Republic
Faculty of Military Health Sciences University of Defense Hradec Kralove Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13016099
- 003
- CZ-PrNML
- 005
- 20200430092007.0
- 007
- ta
- 008
- 130424s2012 xo d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2478/v10102-012-0004-7 $2 doi
- 035 __
- $a (PubMed)22783145
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Pohanka, Miroslav $u Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic $7 hka2010563580
- 245 10
- $a Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in BALB/c mice / $c M. Pohanka, O. Pavlis, H. Svobodova, J. Pikula
- 520 9_
- $a The present experiment was aimed at assessing the application of neostigmine, an acetylcholinesterase (AChE) pseudo-irreversible inhibitor with poor penetration through the hematoencephalitic barrier, and the neurotransmitter acetylcholine (ACh). The experiment was done to evaluate their ability to modulate an infectious disease: tularemia. Mice infected with Franciselle tularensis and exposed to either ACh or neostigmine had a higher mortality and spleen bacterial burden when compared to infected mice exposed to saline solution only. The activated cholinergic anti-inflammatory pathway suppressed pathways necessary for tularemia resolution. Administration of AChE inhibitors to the individuals suffering from tularemia is contra-indicatory. Drugs based on AChE inhibition should be restricted when tularemia or disease with a similar pathogenesis is suspected.
- 650 12
- $a neostigmin $x imunologie $x toxicita $7 D009388
- 650 _2
- $a Francisella tularensis $x patogenita $7 D005604
- 650 12
- $a tularemie $x imunologie $x komplikace $x mortalita $7 D014406
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a acetylcholin $x imunologie $x toxicita $7 D000109
- 650 _2
- $a parasympatický nervový systém $x účinky léků $7 D010275
- 650 _2
- $a zánět $x imunologie $x mikrobiologie $7 D007249
- 650 _2
- $a imunomodulace $7 D056747
- 650 _2
- $a cytokiny $x účinky léků $7 D016207
- 650 _2
- $a výzkum $7 D012106
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pavliš, Oto $7 xx0135660 $u Centre of Biological Defense, Techonin, Czech Republic
- 700 1_
- $a Svobodová, Hana $u Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic $7 _AN065759
- 700 1_
- $a Pikula, Jiří, $u Faculty of Veterinary Hygiene and Ecology, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic $d 1967- $7 mzk2003196544
- 773 0_
- $w MED00174076 $t Interdisciplinary toxicology $x 1337-9569 $g Roč. 5, č. 1 (2012), s. 21-24
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22783145 $y Pubmed
- 910 __
- $a ABA008 $b B 2642 $c 547 $y a $z 0
- 990 __
- $a 20130424 $b ABA008
- 991 __
- $a 20200430092002 $b ABA008
- 999 __
- $a ok $b bmc $g 979300 $s 814420
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 5 $c 1 $d 21-24 $i 1337-9569 $m Interdisciplinary toxicology $n Interdiscip. toxicol. $x MED00174076
- LZP __
- $c NLK185 $d 20180214 $b NLK118 $a Pubmed-20130424